Review
Open access
Sep 2026
Cancer survivorship in malignant melanoma
Robust long‐term survival data have transformed the prognosis of metastatic melanoma. For combination therapy with immune checkpoint inhibitors (ICIs), 10‐year melanoma‐specific survival rates now exceed 50 %, and durable disease control is achievable in a substantial proportion of patients, including those with brain...
Markus Reitmajer, S. Dugas-Breit, C. Blomen et al.
· Journal der Deutschen Dermat... · 0 citations